Citation Impact
Citing Papers
CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation
2014
The Lymphatic System in Health and Disease
2008
Developmental and pathological lymphangiogenesis: from models to human disease
2008
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma
2002
The Lymphangiogenic Vascular Endothelial Growth Factors VEGF-C and -D Are Ligands for the Integrin α9β1
2004
Inference and analysis of cell-cell communication using CellChat
2021 Standout
Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors
2006
EGFR Antagonists in Cancer Treatment
2008 Standout
Vascular Endothelial Growth Factor-C Accelerates Diabetic Wound Healing
2006
Inflammation and cancer
2002 StandoutNature
Lymphangiogenesis and cancer metastasis
2002 Standout
Lymphangiogenesis and tumor metastasis
2003
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
2005 Standout
Molecular mechanisms of lymphangiogenesis in health and disease
2002
Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis
2001
Focus on lymphangiogenesis in tumor metastasis
2005
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
2011
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
2005 Standout
Crystal Structures of Novel Vascular Endothelial Growth Factors (VEGF) from Snake Venoms
2004
Optical microcavities
2003 StandoutNature
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Lymphatic endothelium in health and disease
2008
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
2001
New Insights into the Molecular Control of the Lymphatic Vascular System and its Role in Disease
2006
Cancer Metastasis: Building a Framework
2006 Standout
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
2001
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
2004
Genesis and pathogenesis of lymphatic vessels
2003
Lymphatic filariasis and onchocerciasis
2010 Standout
Lymphangiogenic growth factors as markers of tumor metastasis
2004
Molecular lymphangiogenesis: new players
2005
Characterization of indolinones which preferentially inhibit VEGF‐C‐ and VEGF‐D‐induced activation of VEGFR‐3 rather than VEGFR‐2
2001
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study
2015
Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries
2005
Lymphangiogenic Growth Factor Responsiveness Is Modulated by Postnatal Lymphatic Vessel Maturation
2006
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
2001
Tumor Lymphangiogenesis
2003
Lymphangiogenesis in development and human disease
2005 StandoutNature
Interaction of tumor cells and lymphatic vessels in cancer progression
2011
VEGF receptor signalling ? in control of vascular function
2006 Standout
Survey of the year 2000 commercial optical biosensor literature
2001
Lymphangiogenic growth factors, receptors and therapies
2003
Angiogenesis in life, disease and medicine
2005 StandoutNature
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
2003 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Tumor lymphangiogenesis and metastatic spread—New players begin to emerge
2006
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Modulation of Ocular Surface Glycocalyx Barrier Function by a Galectin-3 N-terminal Deletion Mutant and Membrane-Anchored Synthetic Glycopolymers
2013 StandoutNobel
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
2007
Label-free screening of bio-molecular interactions
2003
Survey of the year 2003 commercial optical biosensor literature
2004
Sox18 induces development of the lymphatic vasculature in mice
2008 StandoutNature
The biology of vascular endothelial growth factors
2005
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Optical biosensors in drug discovery
2002
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation
2004
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
2009
Surface Plasmon Resonance: Applications in Understanding Receptor–Ligand Interaction
2005
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
2002 Standout
Tumor Angiogenesis
2008 Standout
A system for quantifying the patterning of the lymphatic vasculature
2007
Survey of the year 2001 commercial optical biosensor literature
2002
Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
2006
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
2001
Adenovirus-Mediated Gene Transfer of Human Vascular Endothelial Growth Factor-D Induces Transient Angiogenic Effects in Mouse Hind Limb Muscle
2007
A model for gene therapy of human hereditary lymphedema
2001
Vascular Growth Factors and Lymphangiogenesis
2002
Molecular Biology and Pathology of Lymphangiogenesis
2008 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Structural determinants of growth factor binding and specificity by VEGF receptor 2
2010
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
2005
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
CellTalkDB: a manually curated database of ligand–receptor interactions in humans and mice
2020
Constitutive and inducible expression and regulation of vascular endothelial growth factor
2004
Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema
2011
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
2002 StandoutScience
Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene
2006 StandoutNobel
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
2005
Glycogene Expression in Conjunctiva of Patients with Dry Eye: Downregulation of Notch Signaling
2009
Biological Basis of Therapeutic Lymphangiogenesis
2011
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
2005 Standout
Modulation of VEGFR-2–mediated endothelial-cell activity by VEGF-C/VEGFR-3
2003
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
2005
Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD
2016
Deletion of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF-D Is Not Equivalent to VEGF Receptor 3 Deletion in Mouse Embryos
2008
Adenoviral Expression of Vascular Endothelial Growth Factor-C Induces Lymphangiogenesis in the Skin
2001
Nanostructured Plasmonic Sensors
2008 Standout
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation
2018 StandoutNobel
VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues
2000
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
THE LYMPHATIC VASCULATURE: Recent Progress and Paradigms
2005
Adenovirus encoding vascular endothelial growth factor–D induces tissue-specific vascular patterns in vivo
2002
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
2005
Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
2002
VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses
2003
Vascular endothelial growth factor receptor 3 in hypoxia‐induced vascular development
2004
Lymphatic System in Cardiovascular Medicine
2016
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Sally Roufail being referenced
Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers
1999
Multiple Forms of Mouse Vascular Endothelial Growth Factor-D Are Generated by RNA Splicing and Proteolysis
2001
Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis
2001
The Propeptides of VEGF-D Determine Heparin Binding, Receptor Heterodimerization, and Effects on Tumor Biology
2013
Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens
2003
The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and Man
2001
Monoclonal antibodies to vascular endothelial growth factor‐D block its interactions with both VEGF receptor‐2 and VEGF receptor‐3
2000
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
2005
The Angiogenic and Lymphangiogenic Factor Vascular Endothelial Growth Factor-D Exhibits a Paracrine Mode of Action in Cancer
2002
Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
2003
Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2
2007
Proteolytic processing of vascular endothelial growth factor‐D is essential for its capacity to promote the growth and spread of cancer
2011